Concepts (122)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Adenoviridae Infections | 1 | 2018 | 150 | 0.64 | Why? |
| Extracorporeal Membrane Oxygenation | 4 | 2020 | 5002 | 0.46 | Why? |
| Adenoviridae | 1 | 2018 | 1151 | 0.45 | Why? |
| Opportunistic Infections | 1 | 2018 | 602 | 0.44 | Why? |
| Body Mass Index | 1 | 2021 | 4306 | 0.35 | Why? |
| Pneumonia | 1 | 2021 | 5652 | 0.22 | Why? |
| Respiratory Insufficiency | 3 | 2020 | 7301 | 0.21 | Why? |
| Micropore Filters | 1 | 2020 | 51 | 0.21 | Why? |
| Respiration, Artificial | 6 | 2021 | 22116 | 0.21 | Why? |
| Obesity | 1 | 2021 | 7388 | 0.20 | Why? |
| Biomarkers, Pharmacological | 1 | 2020 | 150 | 0.20 | Why? |
| Massachusetts | 2 | 2021 | 1279 | 0.19 | Why? |
| Family Conflict | 1 | 2019 | 50 | 0.19 | Why? |
| Pulmonary Atelectasis | 1 | 2018 | 80 | 0.18 | Why? |
| Lung | 4 | 2021 | 31049 | 0.17 | Why? |
| Organophosphonates | 1 | 2018 | 85 | 0.17 | Why? |
| Cytosine | 1 | 2018 | 92 | 0.17 | Why? |
| Pulmonary Gas Exchange | 1 | 2020 | 414 | 0.17 | Why? |
| Blood Chemical Analysis | 1 | 2021 | 541 | 0.16 | Why? |
| Vasoconstriction | 1 | 2017 | 153 | 0.15 | Why? |
| Respiratory Mechanics | 1 | 2020 | 585 | 0.15 | Why? |
| Pulmonary Circulation | 1 | 2017 | 207 | 0.15 | Why? |
| Diagnosis, Differential | 2 | 2021 | 7220 | 0.14 | Why? |
| Renal Insufficiency | 2 | 2020 | 810 | 0.13 | Why? |
| Critical Illness | 3 | 2021 | 17281 | 0.12 | Why? |
| Radiography, Thoracic | 2 | 2021 | 5486 | 0.12 | Why? |
| Drug Monitoring | 1 | 2020 | 1408 | 0.12 | Why? |
| Stem Cell Transplantation | 1 | 2018 | 531 | 0.12 | Why? |
| Fatal Outcome | 1 | 2021 | 3438 | 0.11 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2018 | 676 | 0.11 | Why? |
| Patient-Centered Care | 1 | 2019 | 860 | 0.11 | Why? |
| Pulmonary Medicine | 1 | 2017 | 706 | 0.10 | Why? |
| Lung Diseases | 2 | 2021 | 2361 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2018 | 904 | 0.10 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.09 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Cough | 1 | 2021 | 4891 | 0.08 | Why? |
| Critical Care | 3 | 2020 | 14081 | 0.08 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.08 | Why? |
| Health Services Needs and Demand | 1 | 2020 | 3419 | 0.07 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.07 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Curriculum | 1 | 2017 | 3083 | 0.06 | Why? |
| Hypoxia | 1 | 2017 | 3626 | 0.06 | Why? |
| Humans | 18 | 2021 | 930598 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.05 | Why? |
| Equipment Failure Analysis | 1 | 2020 | 94 | 0.05 | Why? |
| Societies, Medical | 1 | 2017 | 6907 | 0.05 | Why? |
| Factor Xa | 1 | 2020 | 113 | 0.05 | Why? |
| Endotoxins | 1 | 2018 | 80 | 0.05 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.05 | Why? |
| Bronchoconstriction | 1 | 2017 | 16 | 0.05 | Why? |
| Nasopharynx | 1 | 2018 | 10224 | 0.05 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.04 | Why? |
| Male | 8 | 2021 | 367725 | 0.04 | Why? |
| Biopsy, Needle | 1 | 2018 | 303 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Sheep | 1 | 2018 | 420 | 0.04 | Why? |
| Vasodilator Agents | 1 | 2020 | 344 | 0.04 | Why? |
| Viral Load | 1 | 2018 | 15850 | 0.04 | Why? |
| Endotoxemia | 1 | 2018 | 143 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Reference Standards | 1 | 2020 | 1163 | 0.04 | Why? |
| Teaching Rounds | 1 | 2019 | 208 | 0.04 | Why? |
| Vasoconstrictor Agents | 1 | 2020 | 714 | 0.04 | Why? |
| Random Allocation | 1 | 2018 | 773 | 0.04 | Why? |
| Influenza, Human | 1 | 2020 | 10779 | 0.04 | Why? |
| Tidal Volume | 1 | 2018 | 565 | 0.04 | Why? |
| Fluid Therapy | 1 | 2020 | 628 | 0.04 | Why? |
| Analysis of Variance | 1 | 2018 | 950 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2018 | 893 | 0.04 | Why? |
| Intubation, Intratracheal | 2 | 2020 | 3962 | 0.04 | Why? |
| Evidence-Based Practice | 1 | 2020 | 693 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Risk Factors | 2 | 2021 | 71621 | 0.03 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Patient Care Planning | 1 | 2019 | 582 | 0.03 | Why? |
| Professional-Family Relations | 1 | 2019 | 424 | 0.03 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Adult | 7 | 2020 | 244371 | 0.03 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Administration, Inhalation | 1 | 2020 | 1647 | 0.03 | Why? |
| Positron-Emission Tomography | 1 | 2018 | 802 | 0.03 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.03 | Why? |
| Aged | 4 | 2021 | 215776 | 0.03 | Why? |
| Linear Models | 1 | 2018 | 1914 | 0.03 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.03 | Why? |
| Positive-Pressure Respiration | 1 | 2020 | 1160 | 0.03 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Renal Replacement Therapy | 1 | 2020 | 1530 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.03 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2018 | 1153 | 0.03 | Why? |
| Education, Medical, Continuing | 1 | 2017 | 638 | 0.03 | Why? |
| Patient Positioning | 1 | 2020 | 1505 | 0.02 | Why? |
| Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
| Prone Position | 1 | 2020 | 1861 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Academic Medical Centers | 1 | 2020 | 3088 | 0.02 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.02 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2018 | 5440 | 0.02 | Why? |
| Smoking | 1 | 2020 | 3358 | 0.02 | Why? |
| Time Factors | 2 | 2020 | 31397 | 0.02 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Parents | 1 | 2019 | 2758 | 0.02 | Why? |
| Antiviral Agents | 1 | 2018 | 41703 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.01 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
| Hypertension | 1 | 2020 | 8895 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |
Hibbert's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(122)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(392)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_